Heart Test Laboratories, Inc. (NASDAQ:HSCS) Short Interest Up 164.2% in September

Heart Test Laboratories, Inc. (NASDAQ:HSCS) was the recipient of a significant increase in short interest in September. As of September 15th, there was short interest totalling 104,900 shares, an increase of 164.2% from the August 31st total of 39,700 shares. Based on an average daily volume of 364,400 shares, the days-to-cover ratio is currently 0.3 days. Currently, 13.0% of the shares of the company are short sold.

Wall Street Analysts Forecast Growth

Separately, Ascendiant Capital Markets reiterated a “buy” rating and issued a $15.00 price objective on shares of Heart Test Laboratories in a report on Monday, September 23rd.

Heart Test Laboratories Stock Up 6.6 %

HSCS opened at $5.19 on Friday. Heart Test Laboratories has a twelve month low of $2.36 and a twelve month high of $52.00. The company has a quick ratio of 4.02, a current ratio of 4.49 and a debt-to-equity ratio of 0.08. The firm has a 50 day moving average price of $3.41 and a 200-day moving average price of $6.42. The stock has a market capitalization of $3.40 million, a price-to-earnings ratio of -0.11 and a beta of 3.13.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.